Clinical Trial Update: High Doses of 4-aminopyridine in Clinically Complete Chronic Spinal Cord Injury Patients. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating high doses of 4-aminopyridine in patients with clinically complete chronic spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• 4-aminopyridine (4-aminopyridine)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Spinal Cord Injuries, Chronic | Phase 3 | Status: UNKNOWN